Stay updated on Reslizumab in EGPA: Clinical Trial
Sign up to get notified when there's something new on the Reslizumab in EGPA: Clinical Trial page.

Latest updates to the Reslizumab in EGPA: Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange Detected- Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.SummaryDifference4%

- Check25 days agoChange Detected- Version updated from v3.0.2 to v3.1.0. - New contact details added: multiple phone numbers and an email.SummaryDifference0.1%

- Check40 days agoChange DetectedBump from v3.0.1 to v3.0.2 and removal of 'Back to Top'; no substantive changes to core content.SummaryDifference0.2%

- Check47 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.2%

- Check54 days agoChange DetectedThe web page has added a facility name and location, along with several medical conditions related to respiratory diseases, while removing a significant amount of information about various diseases and conditions, including some previously listed medications.SummaryDifference4%

- Check68 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to Reslizumab in EGPA: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Reslizumab in EGPA: Clinical Trial page.